News

The global trial program for isavuconazole focuses on patients with invasive candidiasis including candidemia and patients with aspergillosis. The program targets two very significant patient groups with high

The Albuferon phase III development program includes two trials to evaluate the efficacy, safety and impact on health-related quality of life of Albuferon in combination with ribavirin, versus

Vernakalant hydrochloride is an investigational new drug for the acute conversion of atrial fibrillation. The two companies have submitted more information after the initial application was rejected. “This

Phenoptin is for patients with phenylketonuria (PKU) who have elevated phenylalanine (Phe) levels. Preliminary data has suggested that Phenoptin has potential to produce significant reductions in blood Phe

The application is supported by data from two phase III clinical studies and three phase II studies in patients with pulmonary arterial hypertension (PAH) and Gilead is asking

This collaboration will develop a new research initiative to improve cancer prevention by using molecular technology to enhance the ability to diagnose and treat patients. To enhance Moffitt’s

The New York Times suggested that Eli Lilly encouraged doctors to use Zyprexa in patients who did not have the condition. Documents containing the details of the marketing

Lucassin will be used to treat patients with type 1 hepatorenal syndrome (HRS), a life-threatening condition characterized by rapid kidney failure in patients with end-stage liver cirrhosis, for

The Department of Health and Human Services (HHS) is under a contract with VaxGen to purchase 75 million doses of its recombinant anthrax vaccine, rPA102, had imposed a